Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 13, 2016 10:56 AM ET

Pharmaceuticals

Company Overview of G1 Therapeutics, Inc.

Company Overview

G1 Therapeutics, Inc. researches and develops small molecule therapies to address unmet needs in oncology. It offers programs including G1T28-1, to protect bone marrow and other organs from side effects of chemotherapy treatments and radiation. The company was formerly known as G-Zero Therapeutics Inc. G1 Therapeutics, Inc. was founded in 2008 and is based in Research Triangle Park, North Carolina.

79 T.W. Alexander Drive

4401 Research Commons

Suite 105

Research Triangle Park, NC 27709

United States

Founded in 2008

Phone:

919-213-9835

Fax:

919-741-5830

Key Executives for G1 Therapeutics, Inc.

Chief Executive Officer and Director
Co-Founder, Director, and Scientific and Clinical Advisor
Co-Founder and Scientific and Clinical Advisor
Chief Medical Officer
Age: 56
Chief Business Officer
Age: 54
Compensation as of Fiscal Year 2015.

G1 Therapeutics, Inc. Key Developments

G1 Therapeutics, Inc. Presents at 18th Annual BIO CEO & Investor Conference 2016, Feb-09-2016 01:30 PM

G1 Therapeutics, Inc. Presents at 18th Annual BIO CEO & Investor Conference 2016, Feb-09-2016 01:30 PM. Venue: The Waldorf Astoria, 301 Park Avenue, New York, New York, United States. Speakers: Mark Velleca, Chief Executive Officer and Director.

G1 Therapeutics, Inc. Presents at Boston Biotech East West CEO Conference, Jan-10-2016 08:30 AM

G1 Therapeutics, Inc. Presents at Boston Biotech East West CEO Conference, Jan-10-2016 08:30 AM. Venue: Four Seasons Hotel, 757 Market St., San Francisco, CA 94103, United States. Speakers: Mark Velleca, Chief Executive Officer and Director.

G1 Therapeutics, Inc. Presents at Stifel Healthcare Conference 2015, Nov-17-2015 10:15 AM

G1 Therapeutics, Inc. Presents at Stifel Healthcare Conference 2015, Nov-17-2015 10:15 AM. Venue: The New York Palace Hotel, Hubbard Room, New York, New York, United States. Speakers: Mark Velleca, Chief Executive Officer and Director.

Similar Private Companies By Industry

Company Name Region
Emergent Product Development Seattle LLC United States
Kucera Pharmaceutical Company United States
Myomics, Inc. United States
MultiCell Immunotherapeutics, Inc. United States
Cloud Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact G1 Therapeutics, Inc., please visit www.g1therapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.